Skip to main content

Table 1 Pooled prevalence of VRE in Egypt by subgroups

From: Prevalence of Vancomycin-resistant enterococci (VRE) in Egypt (2010–2022): a systematic review and meta-analysis

Subgroup

Included studies

Pooled prevalence(%) and 95% CI

Total number of enterococci

I2

Heterogeneity

Heterogeneity

test, P value

Publication bias testing

Egger’s test

Begg’s test

Based on AST

 VRE among total enterococci by disk diffusion method

13

24.02

(11.36 to 39.6)

866

96.05%

P < 0.0001

P = 0.0480*

P = 0.0231*

 VRE among total enterococci by MIC-based methods

12

28.25

(15.83 to 42.64)

849

94.85%

P < 0.0001

P = 0.3244

P = 0.6286

 VRE among total enterococci by Broth microdilution

5

26.76

(5.9 to 55.6)

273

95.81%

P < 0.0001

N/PA

N/P

 VRE among total enterococci by E test

5

38.24

(24.7 to 52.78)

395

87.60%

P < 0.0001

N/P

N/P

 VRE among total enterococci by VITEK 2 Automated System

3

13

(5.17 to 23.64)

213

66.53%

P = 0.0504

N/P

N/P

Government

 Mansoura

6

12.45

(3.97 to 24.74)

410

90.61%

P < 0.0001

N/P

N/P

 Cairo

6

19.54

(8 to 34.5)

425

91.66%

P < 0.0001

N/P

N/P

 Minia

3

55.5

(0.186 to 99.5)

123

98.74%

P < 0.0001

N/P

N/P

 Tanta

2

12

(3.2 to 25.5)

143

69.93%

P = 0.0682

N/P

N/P

 Menoufia

2

62.5

(51 to 73.3)

70

0.00%

P = 0.7605

N/P

N/P

 Zagazig

2

21.7

(3.4 to 49.8)

289

96.26%

P < 0.0001

N/P

N/P

 Sohag

2

52.4

(26.7 to 77.5)

125

89.08%

P = 0.0025

N/P

N/P

  1. *Statistically insignificant
  2. ANot performed